Lovastatin Decreases Acute Mucosal Inflammation Via 15-epi-Lipoxin A4

@inproceedings{Planagum2010LovastatinDA,
  title={Lovastatin Decreases Acute Mucosal Inflammation Via 15-epi-Lipoxin A4},
  author={Anna Planagum{\`a} and Michael A. Pfeffer and Geoffrey D. Rubin and Roxanne Croze and Mohib Uddin and Charles N Serhan and Bruce David Levy},
  booktitle={Mucosal Immunology},
  year={2010}
}
The widespread use of statins for hypercholesterolemia has uncovered pleiotropic anti-inflammatory properties that were unexpected based on the drugs' original design; yet, mechanisms for these protective actions remain uncertain. In this study lovastatin triggered biosynthesis of the anti-inflammatory and pro-resolving mediator 15-epi-lipoxin A4 (15-epi-LXA4). During interactions between human neutrophils and airway epithelial cells, the statin-induced increase in 15-epi-LXA4 was associated… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 38 extracted citations

Lipoxins: nature’s way to resolve inflammation

Journal of inflammation research • 2015
View 4 Excerpts
Highly Influenced

Pseudomonas aeruginosa sabotages the generation of host proresolving lipid mediators.

Proceedings of the National Academy of Sciences of the United States of America • 2017

References

Publications referenced by this paper.
Showing 1-10 of 51 references

Similar Papers

Loading similar papers…